nodes	percent_of_prediction	percent_of_DWPC	metapath
Methadyl Acetate—OPRM1—epilepsy syndrome	0.484	1	CbGaD
Methadyl Acetate—Modafinil—Fosphenytoin—epilepsy syndrome	0.0681	0.153	CrCrCtD
Methadyl Acetate—Benzyl Benzoate—Fosphenytoin—epilepsy syndrome	0.0474	0.107	CrCrCtD
Methadyl Acetate—Modafinil—Phenytoin—epilepsy syndrome	0.0467	0.105	CrCrCtD
Methadyl Acetate—Modafinil—Carbamazepine—epilepsy syndrome	0.0431	0.097	CrCrCtD
Methadyl Acetate—Modafinil—Oxcarbazepine—epilepsy syndrome	0.0397	0.0894	CrCrCtD
Methadyl Acetate—Promethazine—Carbamazepine—epilepsy syndrome	0.0365	0.0823	CrCrCtD
Methadyl Acetate—Benzphetamine—Phenytoin—epilepsy syndrome	0.0351	0.079	CrCrCtD
Methadyl Acetate—Promethazine—Oxcarbazepine—epilepsy syndrome	0.0336	0.0758	CrCrCtD
Methadyl Acetate—Benzyl Benzoate—Phenytoin—epilepsy syndrome	0.0325	0.0732	CrCrCtD
Methadyl Acetate—Diphenhydramine—Phenytoin—epilepsy syndrome	0.0311	0.0702	CrCrCtD
Methadyl Acetate—Benzyl Benzoate—Carbamazepine—epilepsy syndrome	0.03	0.0676	CrCrCtD
Methadyl Acetate—OPRM1—telencephalic ventricle—epilepsy syndrome	0.00639	0.306	CbGeAlD
Methadyl Acetate—OPRM1—ganglion—epilepsy syndrome	0.00398	0.19	CbGeAlD
Methadyl Acetate—OPRM1—brainstem—epilepsy syndrome	0.00173	0.0827	CbGeAlD
Methadyl Acetate—OPRM1—forebrain—epilepsy syndrome	0.00167	0.0798	CbGeAlD
Methadyl Acetate—OPRM1—telencephalon—epilepsy syndrome	0.00153	0.0734	CbGeAlD
Methadyl Acetate—OPRM1—midbrain—epilepsy syndrome	0.0011	0.0527	CbGeAlD
Methadyl Acetate—OPRM1—spinal cord—epilepsy syndrome	0.00107	0.0514	CbGeAlD
Methadyl Acetate—OPRM1—head—epilepsy syndrome	0.000955	0.0457	CbGeAlD
Methadyl Acetate—OPRM1—nervous system—epilepsy syndrome	0.000906	0.0433	CbGeAlD
Methadyl Acetate—OPRM1—central nervous system—epilepsy syndrome	0.000872	0.0417	CbGeAlD
Methadyl Acetate—Isoaminile—CA4—epilepsy syndrome	0.000758	0.129	CrCbGaD
Methadyl Acetate—OPRM1—brain—epilepsy syndrome	0.000692	0.0331	CbGeAlD
Methadyl Acetate—Disopyramide—KCND2—epilepsy syndrome	0.000449	0.0762	CrCbGaD
Methadyl Acetate—Loperamide—CACNA1A—epilepsy syndrome	0.00025	0.0424	CrCbGaD
Methadyl Acetate—Diphenoxylate—OPRD1—epilepsy syndrome	0.000235	0.0399	CrCbGaD
Methadyl Acetate—Clidinium—CHRM3—epilepsy syndrome	0.000192	0.0325	CrCbGaD
Methadyl Acetate—Diphenoxylate—OPRM1—epilepsy syndrome	0.00018	0.0305	CrCbGaD
Methadyl Acetate—Clidinium—CHRM1—epilepsy syndrome	0.000179	0.0303	CrCbGaD
Methadyl Acetate—Loperamide—POMC—epilepsy syndrome	0.000173	0.0294	CrCbGaD
Methadyl Acetate—Isopropamide—CHRM3—epilepsy syndrome	0.000163	0.0276	CrCbGaD
Methadyl Acetate—Mepenzolate—CHRM3—epilepsy syndrome	0.000154	0.0261	CrCbGaD
Methadyl Acetate—Isopropamide—CHRM1—epilepsy syndrome	0.000152	0.0258	CrCbGaD
Methadyl Acetate—Doxylamine—CHRM1—epilepsy syndrome	0.000152	0.0258	CrCbGaD
Methadyl Acetate—Mepenzolate—CHRM1—epilepsy syndrome	0.000144	0.0244	CrCbGaD
Methadyl Acetate—Diphenidol—CHRM3—epilepsy syndrome	0.000135	0.0229	CrCbGaD
Methadyl Acetate—Orphenadrine—SCN9A—epilepsy syndrome	0.000129	0.0219	CrCbGaD
Methadyl Acetate—Diphenidol—CHRM1—epilepsy syndrome	0.000126	0.0214	CrCbGaD
Methadyl Acetate—Disopyramide—CHRM3—epilepsy syndrome	0.000124	0.021	CrCbGaD
Methadyl Acetate—Orphenadrine—SCN4A—epilepsy syndrome	0.000118	0.0201	CrCbGaD
Methadyl Acetate—Mepenzolate—CHRM2—epilepsy syndrome	0.000117	0.0199	CrCbGaD
Methadyl Acetate—Disopyramide—CHRM1—epilepsy syndrome	0.000115	0.0195	CrCbGaD
Methadyl Acetate—Diphenidol—CHRM2—epilepsy syndrome	0.000103	0.0174	CrCbGaD
Methadyl Acetate—Dextropropoxyphene—OPRD1—epilepsy syndrome	0.000102	0.0174	CrCbGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CHRM3—epilepsy syndrome	9.9e-05	0.00218	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—BDKRB2—epilepsy syndrome	9.89e-05	0.00218	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—ACKR4—epilepsy syndrome	9.78e-05	0.00215	CbGpPWpGaD
Methadyl Acetate—Loperamide—OPRD1—epilepsy syndrome	9.75e-05	0.0165	CrCbGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—SSTR5—epilepsy syndrome	9.74e-05	0.00214	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—SSTR4—epilepsy syndrome	9.74e-05	0.00214	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—CNR1—epilepsy syndrome	9.71e-05	0.00214	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CX3CR1—epilepsy syndrome	9.5e-05	0.00209	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—HTR7—epilepsy syndrome	9.47e-05	0.00208	CbGpPWpGaD
Methadyl Acetate—Disopyramide—CHRM2—epilepsy syndrome	9.41e-05	0.016	CrCbGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CCR10—epilepsy syndrome	9.34e-05	0.00205	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CHRM2—epilepsy syndrome	9.31e-05	0.00205	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—BDKRB1—epilepsy syndrome	9.31e-05	0.00205	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CX3CL1—epilepsy syndrome	9.31e-05	0.00205	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—IL1B—epilepsy syndrome	9.13e-05	0.00201	CbGpPWpGaD
Methadyl Acetate—Levomethadyl Acetate—OPRM1—epilepsy syndrome	9.06e-05	0.0154	CrCbGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—GABBR1—epilepsy syndrome	9.06e-05	0.00199	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—SST—epilepsy syndrome	9.01e-05	0.00198	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR2—epilepsy syndrome	9.01e-05	0.00198	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—JUN—epilepsy syndrome	8.85e-05	0.00195	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—SSTR4—epilepsy syndrome	8.85e-05	0.00195	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—SSTR5—epilepsy syndrome	8.85e-05	0.00195	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—epilepsy syndrome	8.82e-05	0.00194	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—HRH3—epilepsy syndrome	8.68e-05	0.00191	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—CCR5—epilepsy syndrome	8.66e-05	0.0019	CbGpPWpGaD
Methadyl Acetate—Orphenadrine—SCN1A—epilepsy syndrome	8.65e-05	0.0147	CrCbGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CCR10—epilepsy syndrome	8.48e-05	0.00187	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL12—epilepsy syndrome	8.48e-05	0.00186	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—epilepsy syndrome	8.48e-05	0.00186	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CNR1—epilepsy syndrome	8.32e-05	0.00183	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—GRM2—epilepsy syndrome	8.17e-05	0.0018	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR7—epilepsy syndrome	8.12e-05	0.00178	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CCR3—epilepsy syndrome	8.07e-05	0.00178	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—AGT—epilepsy syndrome	8.04e-05	0.00177	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—NPY—epilepsy syndrome	7.87e-05	0.00173	CbGpPWpGaD
Methadyl Acetate—Dextropropoxyphene—OPRM1—epilepsy syndrome	7.83e-05	0.0133	CrCbGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—OXT—epilepsy syndrome	7.59e-05	0.00167	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CCL3—epilepsy syndrome	7.59e-05	0.00167	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CXCL2—epilepsy syndrome	7.59e-05	0.00167	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CRH—epilepsy syndrome	7.59e-05	0.00167	CbGpPWpGaD
Methadyl Acetate—Loperamide—OPRM1—epilepsy syndrome	7.46e-05	0.0127	CrCbGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—GRM2—epilepsy syndrome	7.42e-05	0.00163	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—SSTR3—epilepsy syndrome	7.39e-05	0.00162	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—CCR5—epilepsy syndrome	7.31e-05	0.00161	CbGpPWpGaD
Methadyl Acetate—Propiomazine—CHRM3—epilepsy syndrome	7.12e-05	0.0121	CrCbGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—NPY2R—epilepsy syndrome	7.08e-05	0.00156	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CCR8—epilepsy syndrome	7.08e-05	0.00156	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—ARHGEF9—epilepsy syndrome	7.08e-05	0.00156	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CCR9—epilepsy syndrome	7.08e-05	0.00156	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—SSTR1—epilepsy syndrome	7.08e-05	0.00156	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—GRM3—epilepsy syndrome	6.94e-05	0.00153	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—GRM4—epilepsy syndrome	6.94e-05	0.00153	CbGpPWpGaD
Methadyl Acetate—Methadone—OPRD1—epilepsy syndrome	6.94e-05	0.0118	CrCbGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CCR2—epilepsy syndrome	6.86e-05	0.00151	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—SST—epilepsy syndrome	6.86e-05	0.00151	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—AVP—epilepsy syndrome	6.83e-05	0.0015	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—SSTR2—epilepsy syndrome	6.82e-05	0.0015	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—AGT—epilepsy syndrome	6.78e-05	0.00149	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—epilepsy syndrome	6.78e-05	0.00149	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—POMC—epilepsy syndrome	6.77e-05	0.00149	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—ADRA2A—epilepsy syndrome	6.72e-05	0.00148	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—SSTR3—epilepsy syndrome	6.71e-05	0.00147	CbGpPWpGaD
Methadyl Acetate—OPRM1—IL4-mediated signaling events—AKT1—epilepsy syndrome	6.65e-05	0.00146	CbGpPWpGaD
Methadyl Acetate—Propiomazine—CHRM1—epilepsy syndrome	6.64e-05	0.0113	CrCbGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—epilepsy syndrome	6.64e-05	0.00146	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—CCL2—epilepsy syndrome	6.62e-05	0.00146	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PRICKLE1—epilepsy syndrome	6.61e-05	0.00145	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PRDM4—epilepsy syndrome	6.61e-05	0.00145	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—GRM8—epilepsy syndrome	6.58e-05	0.00145	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—BDKRB2—epilepsy syndrome	6.45e-05	0.00142	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CXCL12—epilepsy syndrome	6.45e-05	0.00142	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—NPY2R—epilepsy syndrome	6.43e-05	0.00141	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CCR8—epilepsy syndrome	6.43e-05	0.00141	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—ARHGEF9—epilepsy syndrome	6.43e-05	0.00141	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CCR9—epilepsy syndrome	6.43e-05	0.00141	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—SSTR1—epilepsy syndrome	6.43e-05	0.00141	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CNR1—epilepsy syndrome	6.34e-05	0.00139	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—GRM4—epilepsy syndrome	6.31e-05	0.00139	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—GRM3—epilepsy syndrome	6.31e-05	0.00139	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—OPRD1—epilepsy syndrome	6.28e-05	0.00138	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—SSTR2—epilepsy syndrome	6.19e-05	0.00136	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—HTR7—epilepsy syndrome	6.18e-05	0.00136	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—PDYN—epilepsy syndrome	6.02e-05	0.00132	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CCR7—epilepsy syndrome	6.02e-05	0.00132	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CHRM1—epilepsy syndrome	6.02e-05	0.00132	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—GRM1—epilepsy syndrome	6.02e-05	0.00132	CbGpPWpGaD
Methadyl Acetate—Promethazine—CHRM3—epilepsy syndrome	6e-05	0.0102	CrCbGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—GRM8—epilepsy syndrome	5.98e-05	0.00131	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—epilepsy syndrome	5.81e-05	0.00128	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—ACKR4—epilepsy syndrome	5.78e-05	0.00127	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—POMC—epilepsy syndrome	5.71e-05	0.00126	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—GNAO1—epilepsy syndrome	5.7e-05	0.00125	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—OPRD1—epilepsy syndrome	5.7e-05	0.00125	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—epilepsy syndrome	5.68e-05	0.00125	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—GAL—epilepsy syndrome	5.66e-05	0.00124	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—GRM5—epilepsy syndrome	5.6e-05	0.00123	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CHRM3—epilepsy syndrome	5.6e-05	0.00123	CbGpPWpGaD
Methadyl Acetate—Promethazine—CHRM1—epilepsy syndrome	5.59e-05	0.00949	CrCbGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CHRM1—epilepsy syndrome	5.47e-05	0.0012	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—PDYN—epilepsy syndrome	5.47e-05	0.0012	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CCR7—epilepsy syndrome	5.47e-05	0.0012	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—GRM1—epilepsy syndrome	5.47e-05	0.0012	CbGpPWpGaD
Methadyl Acetate—Propiomazine—CHRM2—epilepsy syndrome	5.42e-05	0.00919	CrCbGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGT—epilepsy syndrome	5.39e-05	0.00119	CbGpPWpGaD
Methadyl Acetate—Methadone—OPRM1—epilepsy syndrome	5.31e-05	0.00901	CrCbGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—BDKRB1—epilepsy syndrome	5.26e-05	0.00116	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CHRM2—epilepsy syndrome	5.26e-05	0.00116	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—SSTR4—epilepsy syndrome	5.23e-05	0.00115	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—SSTR5—epilepsy syndrome	5.23e-05	0.00115	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—AVP—epilepsy syndrome	5.2e-05	0.00114	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—GAL—epilepsy syndrome	5.14e-05	0.00113	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—GABBR1—epilepsy syndrome	5.12e-05	0.00113	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CHRM3—epilepsy syndrome	5.08e-05	0.00112	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—GRM5—epilepsy syndrome	5.08e-05	0.00112	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CCR10—epilepsy syndrome	5.01e-05	0.0011	CbGpPWpGaD
Methadyl Acetate—Benzphetamine—ADRA2A—epilepsy syndrome	4.96e-05	0.00841	CrCbGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—AKT1—epilepsy syndrome	4.93e-05	0.00108	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—HRH3—epilepsy syndrome	4.91e-05	0.00108	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CX3CR1—epilepsy syndrome	4.87e-05	0.00107	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CHRM2—epilepsy syndrome	4.78e-05	0.00105	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—BDKRB1—epilepsy syndrome	4.78e-05	0.00105	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CX3CL1—epilepsy syndrome	4.78e-05	0.00105	CbGpPWpGaD
Methadyl Acetate—Phenoxybenzamine—ADRA2A—epilepsy syndrome	4.74e-05	0.00804	CrCbGaD
Methadyl Acetate—Diphenhydramine—CHRM2—epilepsy syndrome	4.66e-05	0.0079	CrCbGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—GABBR1—epilepsy syndrome	4.65e-05	0.00102	CbGpPWpGaD
Methadyl Acetate—Promethazine—CHRM2—epilepsy syndrome	4.57e-05	0.00774	CrCbGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CCR3—epilepsy syndrome	4.56e-05	0.001	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	4.54e-05	0.000998	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—HRH3—epilepsy syndrome	4.46e-05	0.00098	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—NPY—epilepsy syndrome	4.45e-05	0.000978	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	4.44e-05	0.000977	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CCR5—epilepsy syndrome	4.42e-05	0.000973	CbGpPWpGaD
Methadyl Acetate—Orphenadrine—CHRM2—epilepsy syndrome	4.4e-05	0.00747	CrCbGaD
Methadyl Acetate—OPRM1—Signaling Pathways—GRM2—epilepsy syndrome	4.38e-05	0.000963	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—HTR2A—epilepsy syndrome	4.33e-05	0.000952	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CRH—epilepsy syndrome	4.29e-05	0.000943	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—OXT—epilepsy syndrome	4.29e-05	0.000943	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CXCL2—epilepsy syndrome	4.29e-05	0.000943	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CCR3—epilepsy syndrome	4.14e-05	0.000911	CbGpPWpGaD
Methadyl Acetate—Modafinil—CYP2C19—epilepsy syndrome	4.14e-05	0.00702	CrCbGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—AGT—epilepsy syndrome	4.11e-05	0.000903	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—NPY—epilepsy syndrome	4.04e-05	0.000888	CbGpPWpGaD
Methadyl Acetate—Tamoxifen—ABCC2—epilepsy syndrome	4.03e-05	0.00683	CrCbGaD
Methadyl Acetate—OPRM1—Signaling Pathways—SSTR3—epilepsy syndrome	3.96e-05	0.000871	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—OXT—epilepsy syndrome	3.9e-05	0.000857	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CRH—epilepsy syndrome	3.9e-05	0.000857	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CCL3—epilepsy syndrome	3.9e-05	0.000857	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CXCL2—epilepsy syndrome	3.9e-05	0.000857	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—SST—epilepsy syndrome	3.88e-05	0.000853	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CCR2—epilepsy syndrome	3.88e-05	0.000853	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—ST3GAL3—epilepsy syndrome	3.88e-05	0.000853	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—ARHGEF9—epilepsy syndrome	3.8e-05	0.000835	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—NPY2R—epilepsy syndrome	3.8e-05	0.000835	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CCR9—epilepsy syndrome	3.8e-05	0.000835	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CCR8—epilepsy syndrome	3.8e-05	0.000835	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—SSTR1—epilepsy syndrome	3.8e-05	0.000835	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—ADRA2A—epilepsy syndrome	3.8e-05	0.000835	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—GRM4—epilepsy syndrome	3.72e-05	0.000819	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—GRM3—epilepsy syndrome	3.72e-05	0.000819	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—DUSP4—epilepsy syndrome	3.66e-05	0.000804	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—SSTR2—epilepsy syndrome	3.66e-05	0.000804	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CXCL12—epilepsy syndrome	3.65e-05	0.000802	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—BDKRB2—epilepsy syndrome	3.65e-05	0.000802	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CNR1—epilepsy syndrome	3.58e-05	0.000787	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—PLCB1—epilepsy syndrome	3.57e-05	0.000784	CbGpPWpGaD
Methadyl Acetate—Tamoxifen—ABCG2—epilepsy syndrome	3.56e-05	0.00604	CrCbGaD
Methadyl Acetate—OPRM1—Signaling Pathways—GRM8—epilepsy syndrome	3.53e-05	0.000777	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PGF—epilepsy syndrome	3.53e-05	0.000777	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CCR2—epilepsy syndrome	3.52e-05	0.000775	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—SST—epilepsy syndrome	3.52e-05	0.000775	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—HTR7—epilepsy syndrome	3.49e-05	0.000768	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—POMC—epilepsy syndrome	3.46e-05	0.00076	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—ADRA2A—epilepsy syndrome	3.45e-05	0.000758	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CCL2—epilepsy syndrome	3.38e-05	0.000744	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—OPRD1—epilepsy syndrome	3.37e-05	0.000741	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—GNAO1—epilepsy syndrome	3.37e-05	0.000741	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—AKT3—epilepsy syndrome	3.33e-05	0.000732	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—BDKRB2—epilepsy syndrome	3.31e-05	0.000728	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CXCL12—epilepsy syndrome	3.31e-05	0.000728	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CNR1—epilepsy syndrome	3.25e-05	0.000715	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—PLCB1—epilepsy syndrome	3.24e-05	0.000712	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CHRM1—epilepsy syndrome	3.23e-05	0.00071	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—GRM1—epilepsy syndrome	3.23e-05	0.00071	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PDYN—epilepsy syndrome	3.23e-05	0.00071	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CCR7—epilepsy syndrome	3.23e-05	0.00071	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—HTR7—epilepsy syndrome	3.17e-05	0.000698	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—HBEGF—epilepsy syndrome	3.08e-05	0.000677	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CDC42—epilepsy syndrome	3.04e-05	0.000668	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—GAL—epilepsy syndrome	3.04e-05	0.000668	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—GFAP—epilepsy syndrome	3.04e-05	0.000668	CbGpPWpGaD
Methadyl Acetate—Dextropropoxyphene—CYP2D6—epilepsy syndrome	3.03e-05	0.00514	CrCbGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—AKT3—epilepsy syndrome	3.02e-05	0.000665	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CHRM3—epilepsy syndrome	3e-05	0.00066	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—GRM5—epilepsy syndrome	3e-05	0.00066	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CASP2—epilepsy syndrome	3e-05	0.00066	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—AVP—epilepsy syndrome	2.94e-05	0.000647	CbGpPWpGaD
Methadyl Acetate—Loperamide—CYP2D6—epilepsy syndrome	2.89e-05	0.0049	CrCbGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CX3CR1—epilepsy syndrome	2.88e-05	0.000633	CbGpPWpGaD
Methadyl Acetate—Diphenhydramine—CYP2C19—epilepsy syndrome	2.87e-05	0.00487	CrCbGaD
Methadyl Acetate—OPRM1—Signaling Pathways—BDKRB1—epilepsy syndrome	2.82e-05	0.000621	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CX3CL1—epilepsy syndrome	2.82e-05	0.000621	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CHRM2—epilepsy syndrome	2.82e-05	0.000621	CbGpPWpGaD
Methadyl Acetate—Tamoxifen—CYP2C19—epilepsy syndrome	2.8e-05	0.00475	CrCbGaD
Methadyl Acetate—Methadone—CYP2C19—epilepsy syndrome	2.77e-05	0.00471	CrCbGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CDC42—epilepsy syndrome	2.76e-05	0.000606	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—GABBR1—epilepsy syndrome	2.75e-05	0.000604	CbGpPWpGaD
Methadyl Acetate—Propiomazine—HTR2A—epilepsy syndrome	2.71e-05	0.0046	CrCbGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—AVP—epilepsy syndrome	2.67e-05	0.000587	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—HRH3—epilepsy syndrome	2.63e-05	0.000579	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CCR5—epilepsy syndrome	2.5e-05	0.00055	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CCR3—epilepsy syndrome	2.45e-05	0.000538	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—HTR2A—epilepsy syndrome	2.45e-05	0.000538	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—NPY—epilepsy syndrome	2.39e-05	0.000525	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—ATP2A2—epilepsy syndrome	2.39e-05	0.000525	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—AGT—epilepsy syndrome	2.32e-05	0.00051	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—HSPB1—epilepsy syndrome	2.3e-05	0.000506	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CXCL2—epilepsy syndrome	2.3e-05	0.000506	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CCL3—epilepsy syndrome	2.3e-05	0.000506	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CRH—epilepsy syndrome	2.3e-05	0.000506	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—OXT—epilepsy syndrome	2.3e-05	0.000506	CbGpPWpGaD
Methadyl Acetate—Promethazine—HTR2A—epilepsy syndrome	2.28e-05	0.00388	CrCbGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CCR5—epilepsy syndrome	2.27e-05	0.000499	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—HTR2A—epilepsy syndrome	2.22e-05	0.000489	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—PRKCB—epilepsy syndrome	2.14e-05	0.000472	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PTK2B—epilepsy syndrome	2.14e-05	0.00047	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—TSC1—epilepsy syndrome	2.14e-05	0.00047	CbGpPWpGaD
Methadyl Acetate—Diphenhydramine—CYP2D6—epilepsy syndrome	2.13e-05	0.00361	CrCbGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—AGT—epilepsy syndrome	2.11e-05	0.000464	CbGpPWpGaD
Methadyl Acetate—Promethazine—CYP2D6—epilepsy syndrome	2.09e-05	0.00354	CrCbGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CCR2—epilepsy syndrome	2.08e-05	0.000458	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—NTRK2—epilepsy syndrome	2.08e-05	0.000458	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—SST—epilepsy syndrome	2.08e-05	0.000458	CbGpPWpGaD
Methadyl Acetate—Tamoxifen—CYP2D6—epilepsy syndrome	2.07e-05	0.00352	CrCbGaD
Methadyl Acetate—Loperamide—ABCB1—epilepsy syndrome	2.06e-05	0.0035	CrCbGaD
Methadyl Acetate—OPRM1—Signaling Pathways—DUSP6—epilepsy syndrome	2.06e-05	0.000454	CbGpPWpGaD
Methadyl Acetate—Methadone—CYP2D6—epilepsy syndrome	2.06e-05	0.00349	CrCbGaD
Methadyl Acetate—OPRM1—Signaling Pathways—ADRA2A—epilepsy syndrome	2.04e-05	0.000448	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PLAT—epilepsy syndrome	2.03e-05	0.000446	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.96e-05	0.00043	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CXCL12—epilepsy syndrome	1.96e-05	0.00043	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—POMC—epilepsy syndrome	1.95e-05	0.00043	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.95e-05	0.000428	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.94e-05	0.000427	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—JUNB—epilepsy syndrome	1.92e-05	0.000422	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CNR1—epilepsy syndrome	1.92e-05	0.000422	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PLCB1—epilepsy syndrome	1.91e-05	0.000421	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—HTR7—epilepsy syndrome	1.87e-05	0.000412	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—HBEGF—epilepsy syndrome	1.82e-05	0.0004	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—AKT3—epilepsy syndrome	1.79e-05	0.000393	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—POMC—epilepsy syndrome	1.77e-05	0.00039	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—ADAM10—epilepsy syndrome	1.74e-05	0.000384	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CCL2—epilepsy syndrome	1.74e-05	0.000382	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—S100B—epilepsy syndrome	1.65e-05	0.000363	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—SOCS3—epilepsy syndrome	1.63e-05	0.000359	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CDC42—epilepsy syndrome	1.63e-05	0.000358	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—AVP—epilepsy syndrome	1.58e-05	0.000347	CbGpPWpGaD
Methadyl Acetate—Promethazine—ABCB1—epilepsy syndrome	1.49e-05	0.00253	CrCbGaD
Methadyl Acetate—OPRM1—Signaling Pathways—HES1—epilepsy syndrome	1.49e-05	0.000328	CbGpPWpGaD
Methadyl Acetate—Tamoxifen—ABCB1—epilepsy syndrome	1.48e-05	0.00251	CrCbGaD
Methadyl Acetate—Methadone—ABCB1—epilepsy syndrome	1.47e-05	0.00249	CrCbGaD
Methadyl Acetate—OPRM1—Signaling Pathways—FYN—epilepsy syndrome	1.45e-05	0.000319	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—H2AFX—epilepsy syndrome	1.45e-05	0.000318	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—MEF2C—epilepsy syndrome	1.44e-05	0.000317	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.39e-05	0.000307	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—NGF—epilepsy syndrome	1.38e-05	0.000303	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CCR5—epilepsy syndrome	1.34e-05	0.000295	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—HTR2A—epilepsy syndrome	1.31e-05	0.000289	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—TSC2—epilepsy syndrome	1.25e-05	0.000274	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—AGT—epilepsy syndrome	1.25e-05	0.000274	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—APOE—epilepsy syndrome	1.22e-05	0.000268	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—KDR—epilepsy syndrome	1.2e-05	0.000263	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PRKCB—epilepsy syndrome	1.15e-05	0.000253	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—IL6ST—epilepsy syndrome	1.15e-05	0.000252	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—POMC—epilepsy syndrome	1.05e-05	0.00023	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CCL2—epilepsy syndrome	1.03e-05	0.000226	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—FGF2—epilepsy syndrome	9.27e-06	0.000204	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—RELA—epilepsy syndrome	8.6e-06	0.000189	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—MTOR—epilepsy syndrome	8.44e-06	0.000186	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	7.83e-06	0.000172	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CASP3—epilepsy syndrome	7.76e-06	0.000171	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—JUN—epilepsy syndrome	7.54e-06	0.000166	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—MMP9—epilepsy syndrome	7.33e-06	0.000161	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—AKT1—epilepsy syndrome	7.11e-06	0.000156	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—SRC—epilepsy syndrome	6.76e-06	0.000149	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—VEGFA—epilepsy syndrome	6.59e-06	0.000145	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—AKT1—epilepsy syndrome	4.2e-06	9.24e-05	CbGpPWpGaD
